Pages that link to "Q53571837"

The following pages link to Role of ribonucleotide reductase in expression in the neoplastic program. (Q53571837):

Displaying 47 items.

• Control of enzymic programs and nucleotide pattern in cancer cells by acivicin and tiazofurin (Q28575513) (← links)
• The regulation of ribonucleoside diphosphate reductase by the tumor promoter orotic acid in normal rat liver in vivo (Q28584327) (← links)
• The Eltrombopag antitumor effect on hepatocellular carcinoma (Q33426135) (← links)
• Modulating radiation resistance by inhibiting ribonucleotide reductase in cancers with virally or mutationally silenced p53 protein (Q33638420) (← links)
• Phase I trial of pelvic radiation, weekly cisplatin, and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) for locally advanced cervical cancer (Q33658330) (← links)
• Role of antimetabolites of purine and pyrimidine nucleotide metabolism in tumor cell differentiation (Q33691162) (← links)
• Metabolic genes in cancer: their roles in tumor progression and clinical implications (Q33772469) (← links)
• Phenotypic changes in mouse leukemia L1210 cells with alterations in the effector-binding subunit of ribonucleotide reductase (Q33927813) (← links)
• Sir Hans A. Krebs Centenary Lecture: cancer and clinical targeting (Q33952279) (← links)
• The efficacy of the ribonucleotide reductase inhibitor Didox in preclinical models of AML. (Q34524753) (← links)
• Iron chelators as therapeutic agents for the treatment of cancer. (Q34671614) (← links)
• Identification of the di-pyridyl ketone isonicotinoyl hydrazone (PKIH) analogues as potent iron chelators and anti-tumour agents (Q35045012) (← links)
• Mycoplasmas and cancer: focus on nucleoside metabolism (Q35728840) (← links)
• Targeting cancer by binding iron: Dissecting cellular signaling pathways (Q36326247) (← links)
• Neuroprotective activity of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (PAN-811), a cancer therapeutic agent. (Q36533485) (← links)
• The application of delivery systems for DNA methyltransferase inhibitors (Q37911496) (← links)
• Fermented wheat germ extract - nutritional supplement or anticancer drug? (Q38557614) (← links)
• Digalloylresveratrol, a novel resveratrol analog inhibits the growth of human pancreatic cancer cells. (Q39110541) (← links)
• Combination effects of digalloylresveratrol with arabinofuranosylcytosine and difluorodeoxycytidine in human leukemia and pancreatic cancer cells (Q39434645) (← links)
• Altered forms of mammalian nucleoside diphosphate reductase from mutant cell lines (Q40167046) (← links)
• Trimidox induces apoptosis via cytochrome c release in NALM-6 human B cell leukaemia cells (Q40325727) (← links)
• Amidox, an inhibitor of ribonucleotide reductase, potentiates the action of Ara-C in HL-60 human promyelocytic leukemia cells (Q40486477) (← links)
• Iron binding capacity of didox (3,4-dihydroxybenzohydroxamic acid) and amidox (3,4-dihydroxybenzamidoxime) new inhibitors of the enzyme ribonucleotide reductase (Q40910416) (← links)
• The Enzyme Ribonucleotide Reductase: Target for Antitumor and Anti-HIV Therapy (Q41687656) (← links)
• Expression of key enzymes of purine and pyrimidine metabolism in a hepatocyte-derived cell line at different phases of the growth cycle (Q41749187) (← links)
• Ribonucleotide reductase inhibitors reduce atherosclerosis in a double-injury rabbit model (Q41761628) (← links)
• Trimidox, an inhibitor of ribonucleotide reductase, synergistically enhances the inhibition of colony formation by Ara-C in HL-60 human promyelocytic leukemia cells (Q44082420) (← links)
• Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells. (Q46326805) (← links)
• Modulation of IMP dehydrogenase activity and guanylate metabolism by tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide) (Q50592121) (← links)
• Inhibition of ribonucleotide reductase and growth of human colon carcinoma HT-29 cells and mouse leukemia L1210 cells by N-hydroxy-N'-aminoguanidine derivatives (Q50877836) (← links)
• Trimidox, an inhibitor of ribonucleotide reductase, induces apoptosis and activates caspases in HL-60 promyelocytic leukemia cells (Q57909874) (← links)
• Enhanced effects of adriamycin by combination with a new ribonucleotide reductase inhibitor, trimidox, in murine leukemia (Q57909882) (← links)
• Simultaneous determination of the new anticancer agent amidox and its metabolites in rat bile and plasma by high-performance liquid chromatography (Q57909887) (← links)
• The new inhibitors of ribonucleotide reductase—comparison of some physico-chemical properties (Q57909890) (← links)
• Iron Binding Capacity of Trimidox (3,4,5-Trihydroxybenzamidoxime), a New Inhibitor of the Enzyme Ribonucleotide Reductase (Q57909894) (← links)
• Biochemical and antitumor activity of trimidox, a new inhibitor of ribonucleotide reductase (Q57909898) (← links)
• Effects of deoxyadenosine on ribonucleotide reductase in adenosine deaminase‐deficient lymphocytes (Q67901396) (← links)
• Lack of correlation between deoxyribonucleotide pool sizes, spontaneous mutation rates and malignant potential in Chinese hamster ovary cells (Q69786074) (← links)
• A simple method to purify ribonucleotide reductase (Q70178363) (← links)
• Identification, Development, and Regional Distribution of Ribonucleotide Reductase in Adult Rat Brain (Q70246894) (← links)
• Regulation of ribonucleotide reductase activity in mammalian cells (Q70284517) (← links)
• Ribonucleotide reductase activity in intact mammalian cells: Stimulation of enzyme activity by MgCl2, dithiothreitol, and several nucleotides (Q70351681) (← links)
• Dynamics of modulation of biochemical programs in cancer cells (Q71093673) (← links)
• Enzymes of purine metabolism in cancer (Q71761703) (← links)
• Studies on the differential mechanisms of inhibition of ribonucleotide reductase by specific inhibitors of the non-heme iron subunit (Q72391866) (← links)
• Iron Binding Capacity of Didox (3,4 Dihydroxybenzohydroxamic Acid) and Amidox (3,4 Dihydroxybenzamidoxime) two Inhibitors of the Enzyme Ribonucleotide Reductase (Q74581066) (← links)
• The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells (Q93081083) (← links)